Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novartis India Limited (NSE: NOVARTIND)

 
NOVARTIND Technical Analysis
1
As on N/A NOVARTIND SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVARTINDSHARE Price

Open N/A Change Price %
High N/A 1 Day N/A N/A
Low N/A 1 Week N/A N/A
Close N/A 1 Month N/A N/A
Volume N/A 1 Year N/A N/A
52 Week High N/A | 52 Week Low N/A
 
NSE INDIA Most Active Stocks
IDEA 7.49 -0.40%
GTLINFRA 1.83 1.10%
RTNPOWER 14.81 0.27%
JPPOWER 18.67 -0.69%
FILATFASH 0.66 -4.35%
TATASTEEL 165.91 0.02%
NYKAA 202.31 -4.39%
YESBANK 20.15 -0.64%
SUZLON 65.27 0.74%
PNB 110.23 -3.18%
 
NSE INDIA Top Gainers Stocks
DELPHIFX 231.59 18.43%
DCMSHRIRAM 1425.50 15.15%
SAKSOFT 225.87 13.08%
UNIVPHOTO 326.99 12.15%
ASAL 627.90 10.02%
GVPTECH 11.12 9.99%
TNTELE 19.18 9.98%
ASTERDM 650.05 9.58%
CONFIPET 56.92 8.83%
ROML 60.93 8.82%
 
NSE INDIA Top Losers Stocks
GATECHDVR 0.64 -5.88%
VSTIND 299.45 -5.15%
SADHNANIQ 7.64 -5.09%
TIJARIA 9.39 -5.06%
ARCHIES 22.31 -5.02%
ABMINTLLTD 67.28 -5.01%
PIGL 118.28 -5.00%
SEMAC 497.20 -5.00%
RELINFRA 376.95 -4.99%
IEL 20.72 -4.91%
 
 
NOVARTIND
Daily Charts		 NOVARTIND
Intraday Charts		 Whats New @
Bazaartrend		 NOVARTIND
Free Analysis
 
NOVARTIND Important Levels Intraday
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
RESISTANCE
 
NOVARTIND Target July 2025
Share
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
NOVARTIND Weekly Target
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
NOVARTIND Target2025
4th UP Target
3rd UP Target
2nd UP Target
1st UP Target
1st DOWN Target
2nd DOWN Target
3rd DOWN Target
4th DOWN Target
 
 
NOVARTIND Synopsis Technicals View
50 Day EMA N/A (Short Term)
 N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
 
NOVARTIND Other Details
Segment EQ
Market Capital 18732115968.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
NOVARTIND Address
NOVARTIND
 
NOVARTIND Latest News
 
Your Comments and Response on Novartis India Limited
 
NOVARTIND Business Profile
Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG. Address: Inspire BKC, G Block, Mumbai, India, 400051
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service